These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7222067)

  • 21. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromuscular effects of fractions of Crotalus scutulatus scutulatus venom.
    Castilonia RR; Pattabhiraman TR; Russell FE
    Proc West Pharmacol Soc; 1979; 22():205-8. PubMed ID: 515051
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of concanavalin A on the hemolytic activity of the components of the classical complement pathway.
    Gee AP; Boyle MD; Langone JJ
    Mol Immunol; 1980 Jan; 17(1):143-6. PubMed ID: 7360112
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptic actions of Mojave toxin isolated from Mojave rattlesnake (crotalus scutulatus) venom.
    Ho CL; Lee CY
    Toxicon; 1981; 19(6):889-92. PubMed ID: 7336451
    [No Abstract]   [Full Text] [Related]  

  • 26. The distribution among ophidian venoms of a toxin isolated from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus).
    Weinstein SA; Minton SA; Wilde CE
    Toxicon; 1985; 23(5):825-44. PubMed ID: 3937297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization.
    French WJ; Hayes WK; Bush SP; Cardwell MD; Bader JO; Rael ED
    Toxicon; 2004 Dec; 44(7):781-91. PubMed ID: 15500854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mojave rattlesnake Crotalus scutulatus scutulatus venom: variation in toxicity with geographical origin.
    Glenn JL; Straight R
    Toxicon; 1978; 16(1):81-4. PubMed ID: 622731
    [No Abstract]   [Full Text] [Related]  

  • 29. Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties.
    Glenn JL; Straight RC; Wolfe MC; Hardy DL
    Toxicon; 1983; 21(1):119-30. PubMed ID: 6342208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A.
    Hardy DL
    Toxicon; 1983; 21(1):111-8. PubMed ID: 6302953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of two disintegrins inhibiting ADP-induced human platelet aggregation from the venom of Crotalus scutulatus scutulatus (Mohave Rattlesnake).
    Sánchez EE; Galán JA; Russell WK; Soto JG; Russell DH; Pérez JC
    Toxicol Appl Pharmacol; 2006 Apr; 212(1):59-68. PubMed ID: 16084550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological studies on a protein fraction (K') from Mojave rattlesnake (Crotalus scutulatus scutulatus) venom.
    Castilonia RR; Pattabhiraman TR; Russell FE; Gonzalez H
    Toxicon; 1981; 19(4):473-9. PubMed ID: 6977206
    [No Abstract]   [Full Text] [Related]  

  • 34. Mohave Rattlesnake (Crotalus scutulatus) Identification Revisited.
    Cardwell MD; Massey DJ; Smelski G; Wüster W
    Wilderness Environ Med; 2022 Jun; 33(2):210-218. PubMed ID: 35221167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Basis for Variation of Metalloproteinase-Associated Biochemical Activity in Venom of the Mojave Rattlesnake (Crotalus scutulatus scutulatus).
    Dagda RK; Gasanov S; De La Oiii Y; Rael ED; Lieb CS
    Biochem Res Int; 2013; 2013():251474. PubMed ID: 23984070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors in snake venoms that increase capillary permeability.
    Miller RA; Tu AT
    J Pharm Pharmacol; 1989 Nov; 41(11):792-4. PubMed ID: 2576052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake.
    Gopalakrishnakone P; Hawgood BJ; Holbrooke SE; Marsh NA; Santana De Sa S; Tu AT
    Br J Pharmacol; 1980 Jul; 69(3):421-31. PubMed ID: 7397452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement inactivating proteins and intraspecies venom variation in Crotalus oreganus helleri.
    Jurado JD; Rael ED; Lieb CS; Nakayasu E; Hayes WK; Bush SP; Ross JA
    Toxicon; 2007 Mar; 49(3):339-50. PubMed ID: 17134729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding effectiveness of anti-r-disintegrin polyclonal antibodies against disintegrins and PII and PIII metalloproteases: An immunological survey of type A, B and A+B venoms from Mohave rattlesnakes.
    Cantú E; Mallela S; Nyguen M; Báez R; Parra V; Johnson R; Wilson K; Suntravat M; Lucena S; Rodríguez-Acosta A; Sánchez EE
    Comp Biochem Physiol C Toxicol Pharmacol; 2017 Jan; 191():168-176. PubMed ID: 27989783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mojave rattlesnakes (Crotalus scutulatus scutulatus) lacking the acidic subunit DNA sequence lack Mojave toxin in their venom.
    Wooldridge BJ; Pineda G; Banuelas-Ornelas JJ; Dagda RK; Gasanov SE; Rael ED; Lieb CS
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Sep; 130(2):169-79. PubMed ID: 11544087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.